1.
Authors' reply to comment on "Cost-effectiveness analysis of Herpes Zoster vaccination in 50-to 85-year-old immunocompetent Belgian cohorts: a comparison between no vaccination, th...
Quality-of-life: a many-splendored thing? Belgian population norms and 34 potential determinants explored by beta regression
2.
3.
Cost-effectiveness analysis of herpes zoster vaccination in 50-to 85-year-old immunocompetent Belgian cohorts : a comparison between no vaccination, the adjuvanted subunit vaccine,...
Economic evaluation of pneumococcal vaccines for adults aged over 50 years in Belgium